New migraine clinical trial guidelines

January 24, 2012

Experts from the International Headache Society (IHS) have developed new recommendations for conduct of acute and preventive migraine clinical trials. The third edition of Migraine Clinical Trials Guidelines is now available in the IHS journal Cephalalgia, which is published by SAGE.

The new represent an expert consensus summary, and recommend a contemporary, standardized, and evidence-based approach to investigators conducting and reporting randomised, controlled clinical trials.

Migraine has increased exponentially since the last set of guidelines was published. Clinical researchers and have accumulated further experience, and the trend is towards large, multi-national and multi-centre studies. Given these developments, it was timely to bring the guidelines up to date.

The IHS stresses that it endorses to the guidelines unless there is scientific justification to deviate from them. They represent research practice parameters and are the highest level in the hierarchy of evidence-based recommendations in the absence of published standards of research practice.

Trials for acute migraine are addressed in the new guidelines' first section, followed by discussions and recommendations relating to clinical trials for migraine prevention. This includes short-term prevention or 'mini-prophylaxis' for predictable , such as those associated with menses. Sub-sections include: patient selection, trial design, evaluation of results and statistics. A toolbox for each type of trial (acute and prevention) is provided at the end.

The guidelines do not include broader discussions of clinical trials methodologies or ethical considerations, which are published elsewhere.

The publication supersedes previous guidelines. The first edition, published by the Clinical Trials Subcommittee of the IHS in 1991, highlighted the complex nature of migraine clinical trial methodologies and offered a road map to clinical investigators who were interested in the field. Widely adopted, these guidelines were the impetus for similar guidelines' development for tension-type headache and cluster headaches as well.

A second edition was published in 2000 and formed the basis for the European Medicines Agency's 2007 publication, Guidelines on Clinical Investigation of Medicinal Products for the Treatment of Migraine.

Despite these former publications, corresponding author Peer Tfelt-Hansen from the Danish Headache Center at the University of Copenhagen says that adherence to the recommendations in the guidelines for clinical trials on acute migraine treatment has not been overwhelming. For instance, less than a third of 145 acute treatment trials cited between 2002 and 2008 used freedom from pain after two hours as their measure of efficacy, as recommended. Almost 40 percent of trials were instead using a decrease in pain levels as a measure of a treatment's effectiveness.

Even so, freedom from pain as the primary measure of treatment efficacy is gaining ground in today. The updated guidelines are essential reading for those active in migraine research. Many more will benefit, as migraines affect more than ten percent of the world's population.

Explore further: Substantial recovery rate with placebo effect in headache treatment

More information: Guidelines for controlled trials of drugs in migraine: Third edition. A guide for investigators is published today, 24th January 2012, in Cephalalgia

Related Stories

Substantial recovery rate with placebo effect in headache treatment

May 23, 2011
Headache is a very common complaint, with over 90% of all persons experiencing a headache at some time in their lives. Headaches commonly are tension-type (TTH) or migraine. They have high socioeconomic impact and can disturb ...

A pill to prevent migraine? Discovery of migraine gene could put it on the horizon

June 1, 2011
The discovery of a gene for migraine holds great promise in the quest for new approaches -- possibly even a pill -- for preventing the disease, says a panel of experts presenting data at the annual scientific meeting of the ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.